Your session is about to expire
← Back to Search
Neuromodulation for Depression and Memory Loss in Older Adults
Study Summary
This trial seeks to explore if brain stimulation therapy can help relieve mood & memory symptoms in older adults with depression & dementia.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My caregiver is at least 21 years old.I don't have conditions or take medications that would make tES unsafe for me.My caregiver is available on weekdays to help with my treatment.You scored 18 or lower on the Montreal Cognitive Assessment (MoCA) during the in-person screening.You have slight problems with memory and thinking, as measured by a test called MoCA with a score of 26 or lower during a face-to-face evaluation.I have a condition like poor eyesight or severe arthritis that makes it hard for me to manage treatments on my own.I understand the study details and agree to participate.I am unable to perform tasks due to blindness or other disabilities.I have an active skin condition like eczema on my scalp.
- Group 1: tDCS prefrontal cortex + tASC angular gyrus in MDD in the context of AD
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the scope of participants in this clinical research?
"Affirmative. According to clinicaltrials.gov, this research trial is presently enrolling participants. It was first posted on January 24th 2023 and the most recent update occurred on July 27th 2023. Presently, they are recruiting for a total of 20 individuals at one site location."
Is enrollment still open for those seeking to participate in this trial?
"Affirmative. The information posted on clinicaltrials.gov suggests that this trial is currently recruiting participants. It was initially published on January 24th 2023 and the details were most recently updated July 27th 2023, with a target of enrolling 20 patients at one location."
Share this study with friends
Copy Link
Messenger